Sign in
8-K

Current Report

MoonLake Immunotherapeutics Filed Acc 0001213900-23-041556

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading ea178889-8k_moonlake.htm…